Myolax (Thiocolchicoside)

Quick links

Choose a section

Quick links to important sections

Advertisements

Myolax (Thiocolchicoside)

Advertisements
Advertisements

Method of action: Muscle Relaxant

Treatment option:

Advertisements

Overview of Myolax (Thiocolchicoside)

Quick Facts

Property Description
Active ingredient Thiocolchicoside
Form Tablets, Capsules, Solution for injection, Topical gels
Pharmacological class Centrally acting skeletal muscle relaxant
General purpose Relief of painful muscular contractures
Origin Semi-synthetic derivative of colchicine

What Type of Medicine is Myolax (Thiocolchicoside)?

Myolax (Thiocolchicoside) is a prescription-only pharmaceutical product whose active substance, Thiocolchicoside, is classified as a centrally acting skeletal muscle relaxant. This medication is specifically intended to be used as an adjuvant treatment in managing painful muscle stiffness. The active agent is a semi-synthetic derivative that originates from colchicoside, which is a natural glycoside. Its classification as centrally acting means its primary effect is achieved by modulating nerve signals in the central nervous system, distinguishing it from agents that act directly on muscle tissue. This application is used for providing relief in scenarios where muscle spasm contributes significantly to discomfort and limited mobility.


Composition, Origin, and Available Forms

The core composition of this medicine is the active substance Thiocolchicoside, which is typically formulated as a single-active ingredient product. To suit different therapeutic needs, the agent is manufactured in multiple dosage forms, corresponding to various administration routes. These pharmaceutical preparations include oral forms, such as tablets or hard capsules; a solution for injection for intramuscular (IM) administration; and various topical preparations, including gels or ointments, designed for localized application. The compound has a structural relationship to colchicine and is classified as a muscle relaxant.


How Does Thiocolchicoside Generally Help Muscle Tension?

The general purpose of Thiocolchicoside is to provide relief from the discomfort and limitation of movement caused by painful, involuntary muscular contractures. It achieves this through a high-level spasmolytic action that helps to restore normal muscle tone. This antispasmodic effect is rooted in its ability to selectively modulate inhibitory nerve signals within the central nervous system, particularly by influencing neurotransmitter pathways such as the glycine receptor. This results in the desired reduction of hypertonia and subsequent muscle relaxation, offering general symptomatic relief for issues like acute back stiffness.

Advertisements

What side effects are possible with Myolax (Thiocolchicoside)?

Possible Side Effects and Safety Information

The safety profile of Thiocolchicoside is formally classified by regulatory authorities based on the frequency and nature of documented adverse reactions. These effects are grouped into System-Organ Classes (SOCs), reflecting the part of the body affected.

Common adverse reactions, defined as affecting up to 1 in 10 people, include effects on the nervous system such as somnolence (drowsiness), and gastrointestinal disturbances like diarrhea and stomach pain (gastralgia). Uncommon reactions, affecting up to 1 in 100 people, may include nausea, vomiting, and certain hypersensitivity reactions (e.g., pruritus, erythema).

Serious adverse reactions are also officially documented, though many occur with Rare or Frequency Unknown status. These clinically significant events include severe anaphylactic shock, angioedema, and the potential for convulsions (seizures). Post-marketing surveillance has also noted cases of hepatic injury.

Safety Consideration Regulatory Status
Pregnancy and Lactation Contraindicated
Women of Childbearing Potential Contraindicated without effective contraception
Paediatric Use Contraindicated under 16 years of age

The most significant restriction on use stems from regulatory findings regarding the potential for genotoxicity (damage to cell DNA) associated with a major metabolite. Due to this risk, the drug is contraindicated in pregnancy and is subject to mandatory contraceptive use for women of childbearing potential. Furthermore, regulatory guidelines advise against long-term exposure or using doses exceeding the recommended levels.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory description of a Myolax (Thiocolchicoside) overdose focuses on specific documented clinical manifestations and mandated emergency actions. All overdose information is strictly derived from official governmental prescribing information.


Documented Overdose Signs and Outcomes

A suspected overdose may be associated with digestive signs, primarily manifesting as diarrhoea and vomiting. Reports also indicate the possibility of somnolence (drowsiness) in connection with high exposure. The most severe outcomes requiring immediate intervention include the potential for a seizure or a relapsed seizure attack, particularly in individuals with pre-existing epilepsy. Regulatory documents also highlight the risk of severe hypersensitivity reactions such as anaphylactic shock, which constitutes a life-threatening medical emergency.


Required Emergency Actions

In the event of a suspected or confirmed overdose, the official guidance states that immediate action must be taken. It is essential to seek a doctor's advice or call the poison control centre without delay. Monitoring by a physician is a required procedure for overdose management, and the official mandated treatment is symptomatic treatment. The regulatory profile notes that no specific antidote is known for Thiocolchicoside. Treatment therefore focuses on supportive care, with immediate emergency medical assistance required if severe signs like seizures or anaphylactic shock occur.

Advertisements

Therapeutic Uses of Myolax (Thiocolchicoside)

What Myolax (Thiocolchicoside) Treats: Main Uses and Benefits

Myolax (Thiocolchicoside) is used for managing symptoms of increased neurological or muscular activity, such as painful muscle spasms and associated stiffness and tension. It contributes to easing the overall symptom load and offers symptomatic relief. Thiocolchicoside is intended as an adjuvant treatment for painful muscle contractures resulting from spinal conditions in adults and adolescents aged 16 years and older.

The medication provides supportive relief in conditions characterized by periods of heightened symptoms and increased discomfort, and is considered relevant for easing manifestations like lumbago (acute low back pain) and other acute spinal issues. It supports patients during difficult episodes by easing distress and may assist with maintaining a sense of stability when symptoms interfere with daily functioning.

“It contributes to providing symptomatic relief and helps ease the overall symptom burden.”

Quick Fact: Relief for Painful Muscle Spasms and Stiffness

This medicine is often applied during phases when symptoms become more noticeable, helping to manage symptoms that interfere with daily comfort and supports general well-being during symptomatic phases.

Advertisements

Eligibility and Restrictions for Use

Official Regulatory Eligibility Profile

This section outlines the populations determined to be eligible or non-eligible for Myolax (Thiocolchicoside) based strictly on authoritative governmental regulatory documents, such as those published by the European Medicines Agency (EMA) or national health agencies.

Eligibility Status Population/Condition
Contraindicated Pregnant women (entire period)
Contraindicated Breastfeeding women (lactation)
Contraindicated Women of childbearing potential not using effective contraception
Contraindicated Children and adolescents under 16 years of age
Contraindicated Hypersensitivity to the active substance or excipients

Age-Related Eligibility and Restrictions

Use is contraindicated in children and adolescents under 16 years old. It is authorized only for use in adults and adolescents from 16 years onwards, and is generally restricted to short-term use, not for chronic (long-term) conditions, as a regulatory precaution to minimize risks associated with a known genotoxic metabolite.

Conditional Use and Exclusionary Conditions

Use requires caution and clinical monitoring for patients with epilepsy or a history of seizures, and the treatment must be stopped if seizures occur. Furthermore, certain hereditary metabolic disorders (e.g., total lactase deficiency) are listed as an exclusion for specific oral formulations containing lactose excipients. The official eligibility profile is defined by these absolute exclusions and specific cautionary measures, stemming from a safety review regarding the potential for aneuploidy.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory profile for Myolax (Thiocolchicoside) interactions focuses on potential pharmacodynamic reinforcement and specific exposure-related toxicity warnings as documented in official government labeling.


Documented Interaction Patterns

Category Official Regulatory Statement
Pharmacodynamic Interaction Co-administration with other muscle relaxants that act on the musculo-skeletal system is not recommended due to the risk of an additive effect.
Combining the medicine with other agents that produce effects on the smooth muscles carries a possible increase in the incidence rate of side effects.
Exposure/Toxicity Risk Co-administration with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Paracetamol has been associated with post-marketing reports of serious liver conditions.
Metabolic/PK Status No specific CYP-mediated or transporter-based interactions are documented in official prescribing information. The status of the interaction with alcohol is officially unknown.

Population and Condition-Specific Cautions

The official labeling includes cautions that dictate use based on patient risk factors:

  • The medicine may predispose to seizures, dictating a special precaution for patients with existing epilepsy or seizure risks.
  • Patients with pre-existing hepatic conditions may be at a higher risk for the reported serious liver conditions when co-administered with NSAIDs or Paracetamol.

No mandatory timing rules are documented that require administration separation between Thiocolchicoside and other products.

Advertisements

Mechanism of Action

How Myolax (Thiocolchicoside) Works

Targeted Augmentation of Spinal Inhibitory Signals

The primary action of Thiocolchicoside is achieved through a glycomimetic effect, where an active metabolite functions as a selective agonist at the glycine receptors ( GlyR), primarily within the spinal cord and brain stem. By binding to the GlyR, the drug amplifies inhibitory nerve traffic within the spinal cord. This molecular action leads to the hyperpolarization of motor neurons, which modulates heightened motor reflex activity. This alters the efferent motor output, resulting in the physiological state of reduced muscular hypertonia.

Dual Modulation of Central GABAergic Pathways

Thiocolchicoside also influences the inhibitory pathways governed by the GABA A receptor system in the CNS. The overall muscle-relaxing action is associated with an indirect enhancement of GABAergic inhibition in supraspinal centers, which occurs in conjunction with the spinal action. However, the parent drug and a metabolite also exhibit a competitive antagonistic property at this receptor, representing a key mechanistic characteristic defined by a tendency towards neuronal hyperexcitability. The physiological consequence is central spasmolysis—a modulation of nerve traffic within the CNS that alters muscle tone.

Advertisements

Dosage and Administration Information

How Myolax (Thiocolchicoside) is Used: Official Administration Guidelines

Myolax (Thiocolchicoside) is a prescription medicine that is administered according to established protocols defining the route, dose, and duration of use. This medication is intended only as adjuvant treatment for painful muscle contractures in adults and adolescents aged 16 years and older.


Approved Systemic Dosing and Frequency

Thiocolchicoside is available for systemic use via the oral route (tablets/capsules) and the intramuscular (IM) injection route. The maximum dosage is strictly limited to minimize potential risks:

Route of Administration Maximum Single Dose Maximum Daily Dose Frequency Max Treatment Duration
Oral 8 mg 16 mg Twice daily (every 12 hours) 7 consecutive days
Intramuscular (IM) 4 mg 8 mg Twice daily (every 12 hours) 5 consecutive days

High-Level Administration Rules

  • Oral Intake: Tablets or capsules should generally be taken during or after meals.
  • Duration: Treatment must be limited to the specified short-term periods (5 or 7 days) and doses exceeding the recommended maximums must be avoided.
  • Age Restriction: The standard prescribing information explicitly states that Thiocolchicoside is not authorized for use in children and adolescents under 16 years of age.

These instructions define the standardized, limited-course protocol for using the medication as outlined in standard prescribing information.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Mechanism of Action (Studies)

Research has explored the drug's components and their potential involvement in targeting pain transmission and inflammation. Studies have evaluated the drug’s impact on areas related to painful muscle contractures.


Efficacy Data

Studies have evaluated this medication for its use as an adjunctive treatment for painful muscle contractures, particularly those associated with spinal conditions. Research reports observed changes in symptoms among participants, especially in cases of acute low back pain and cervical myofascial pain syndrome.

Key Clinical Trial Observations

A systematic review and meta-analysis of randomized controlled trials (RCTs) examining thiocolchicoside for acute musculoskeletal pain noted observed changes in pain intensity (measured by the Visual Analogue Scale). Studies comparing thiocolchicoside in combination with non-steroidal anti-inflammatory drugs (NSAIDs) versus NSAIDs alone reported a greater observed change in pain severity and functional status with the combination.

In these studies, the primary endpoints tracked changes in pain severity, mobility assessments, and the global assessment of the condition.


Safety and Tolerability Profile

Research has examined the overall safety and tolerability of the drug. The European Medicines Agency (EMA) has recommended restrictions on its use due to safety concerns.

Risk and Safety Findings

A major safety concern involves a metabolite of thiocolchicoside, which experimental studies suggest may have the potential to cause aneuploidy (changes in chromosome number) at exposures close to those seen with recommended doses. Aneuploidy is considered a risk factor for teratogenicity (harm to a fetus) and impaired male fertility.

Due to these findings, the maximum recommended dosage and duration of treatment have been restricted, and the medication is contraindicated (must not be used) in:

  • Pregnant or breastfeeding women.
  • Women of childbearing potential not using effective contraception.
  • Patients with a history of seizures or who are at risk of seizures.

Commonly reported adverse events in trials include mild gastrointestinal discomfort, diarrhea, and drowsiness. The medicine is now recommended only for short-term use as an add-on therapy for painful muscle contractures.

Key Studies & References

  1. Efficacy and Safety of the Combination of Diclofenac and Thiocolchicoside in the Treatment of Low Back Pain and Other Conditions: Systematic Review of the Literature
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Myolax (Thiocolchicoside) (FAQ)


Q: Is Myolax considered a painkiller or a muscle relaxant?

According to official product information, Myolax (Thiocolchicoside) is classified as a centrally acting skeletal muscle relaxant. It is used specifically as an add-on treatment (adjuvant) to relieve painful muscle contractures by modulating nerve signals, rather than being primarily classified as a general painkiller (analgesic).


Q: Is Myolax an NSAID, or is it a different class of medicine?

Myolax is not a Non-Steroidal Anti-Inflammatory Drug (NSAID); it belongs to a different class of medicine: centrally acting skeletal muscle relaxants. This is an important distinction, as the official labeling advises caution when Myolax is taken alongside NSAIDs or Paracetamol.


Q: How long does the effect of one Myolax tablet typically last?

Regulatory information specifies that the drug is authorized for administration with a frequency of twice daily during the short-term course of treatment. The duration of the entire course is limited to a few consecutive days.


Q: Does Myolax only treat symptoms, or does it help with the underlying problem?

Official information states that Myolax is only intended as an adjuvant treatment. This means its primary role is to help relieve the uncomfortable symptoms of painful muscle spasms and stiffness, rather than attempting to treat the underlying medical condition that caused the spasm.


Q: Can Myolax cause any adverse effects on the liver or kidneys?

Post-marketing safety surveillance has noted cases of hepatic injury (damage to the liver) associated with this medication. Specific warnings regarding primary renal (kidney) toxicity are not as commonly emphasized in the core labeling as the warnings regarding hepatic injury.


Q: Are there any known medications that Myolax should not be taken with?

Official labeling advises that concurrent use with other muscle relaxants that act on the musculo-skeletal system is not recommended due to the risk of additive effects. Discussing all concurrent medicines with a healthcare professional is standard practice.


Q: Does Myolax interact with common over-the-counter pain relievers (like ibuprofen or acetaminophen)?

The official labeling advises caution when Myolax is used with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as Ibuprofen, or with Paracetamol (Acetaminophen). This warning is based on post-marketing reports of serious liver conditions when these medicines were used together.


Q: What are the warnings regarding using Myolax with alcohol?

Because Myolax has the potential to cause drowsiness, combining it with alcohol may enhance the sedative effect, increasing the risk of drowsiness or impaired motor skills. Official product information should always be consulted for specific warnings.


Q: Is it better to take Myolax with food or on an empty stomach?

To minimize potential gastrointestinal discomfort, the official prescribing information states that oral forms of Myolax (tablets or capsules) should generally be taken during or immediately after meals.


Q: Why do some people use Myolax for pain in the neck or shoulder area?

Studies have evaluated the drug's effectiveness for painful muscle contractures, including those linked to spinal conditions such as cervical myofascial pain syndrome. This syndrome is a common cause of pain and stiffness in the neck and shoulder area.


Q: Can Myolax be taken with antacids to help with stomach upset?

Official prescribing information indicates that Myolax tablets can generally be used with antacids for the management of gastrointestinal discomfort. Consultation with a healthcare professional is always recommended regarding concurrent use.


Q: Why is Myolax not authorized for use in children and adolescents under 16 years of age?

The use of Myolax is strictly contraindicated (must not be used) in children and adolescents under 16 years old. This restriction is based on safety concerns related to one of the drug's metabolites, which demonstrated the potential to cause chromosome damage (aneuploidy) in non-clinical studies.


Q: What should I do if a common side effect like drowsiness is bothersome?

If drowsiness (somnolence) becomes bothersome or persistent, consultation with a healthcare professional is necessary. They can assess the symptom within the context of the required short-term treatment course.


Q: Does Myolax affect my ability to drive or operate machinery?

Official labeling notes that the side effect of drowsiness (somnolence) may occur with Myolax. Patients should be aware of their individual reaction to the medicine and exercise caution before driving or operating machinery, particularly at the start of treatment.


Q: Is it normal to experience a dry mouth while taking this medication?

Dry mouth is not listed as a common or uncommon side effect in the official regulatory documentation. Any suspected side effect, including dry mouth, should be reviewed with a healthcare professional.


Q: Is Myolax safe for adolescents (over 16 years old)?

Myolax is authorized for use in adolescents who are 16 years and older, provided they adhere strictly to the maximum recommended short-term dose and duration limits established by regulatory bodies.


Q: Can I stop taking Myolax as soon as my pain is relieved?

Changes to the prescribed treatment plan, including discontinuation, should always be discussed with the prescribing doctor. The drug is intended for a short, limited course, which should not be exceeded.


Q: What is the significance of the 4mg dosage often seen with Thiocolchicoside?

The 4 mg dose is significant because it represents the maximum single dose permitted for the intramuscular (IM) injection route. This strict limit, along with the oral dose restrictions, is a safety measure imposed by regulators.


Q: Does Myolax affect blood pressure?

While it is not listed as a common effect, a severe allergic reaction (anaphylactic shock) is a rare but documented adverse event. Anaphylactic shock can cause a sudden and significant drop in blood pressure (hypotension).


Q: Is Myolax used for conditions other than muscle spasms, like arthritis-related stiffness?

The approved indication is solely for the adjuvant treatment of painful muscle contractures associated with acute spinal pathology. Its official use is not extended to chronic conditions or stiffness related to conditions like arthritis.


Q: What is the mechanism by which Thiocolchicoside affects the spinal cord and brain centers?

The muscle-relaxing effect is achieved through central action, primarily by acting as an agonist on the glycine receptors in the brain stem and spinal cord. This mechanism modulates nerve signals and helps to reduce excessive muscle tone (hypertonia).


Q: Does Myolax interact with any medications that cause drowsiness or sedation?

Yes, co-administration with other agents that produce effects on the smooth muscles or other Central Nervous System (CNS) sedatives is a known risk. Combining these medicines can increase the likelihood and severity of side effects such as drowsiness.


Q: What should I do if I forget to take a dose of Myolax?

General guidance for missed doses suggests taking the dose if remembered soon after, unless it is nearly time for the next scheduled dose. If so, skip the missed dose and resume your regular schedule. Patients are generally advised not to take a double dose to make up for a missed one.

Advertisements

How should Myolax (Thiocolchicoside) be stored and disposed of?

How to Store and Dispose of Myolax (Thiocolchicoside)?

Storage Requirements

Myolax (thiocolchicoside) must be stored according to official regulatory specifications. The medicine should be kept at a temperature below 30°C in a cool and dry place, protected from excessive heat and moisture. It is mandatory to keep the product in its original container and maintain the container tightly closed when not in use. A crucial safety requirement is to store the medicine out of the sight and reach of children.

Disposal Instructions

Unused or expired Myolax must be disposed of properly, complying with local regulations for pharmaceutical waste. The product must not be thrown into household waste or disposed of via wastewater (e.g., flushed down the toilet). For the injectable solution, any remaining content in the single-use ampoule must be discarded immediately after administration.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Myolax (Thiocolchicoside) found in:

A-Z Index: